Evidence map›Paper›PMID 32685475›Full record

ArticleBioMed research international2020

Ghedeir M Alshammari, Aristatile Balakrishnan, Ali A Alshatwi, Abdulrahman Al-Khalifa

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ghedeir M AlshammariAdipocytes and Metabolic Disorders Lab, Department of Food Science and Nutrition, College of Food and Agricultural Science, King Saud University, P.O. Box 2460, Riyadh 11451, Saudi Arabia.ORCID https://orcid.org/0000-0002-0805-6725
Aristatile BalakrishnanAdipocytes and Metabolic Disorders Lab, Department of Food Science and Nutrition, College of Food and Agricultural Science, King Saud University, P.O. Box 2460, Riyadh 11451, Saudi Arabia.ORCID https://orcid.org/0000-0002-9632-3095
Ali A AlshatwiAdipocytes and Metabolic Disorders Lab, Department of Food Science and Nutrition, College of Food and Agricultural Science, King Saud University, P.O. Box 2460, Riyadh 11451, Saudi Arabia.ORCID https://orcid.org/0000-0002-2441-553X
Abdulrahman Al-KhalifaAdipocytes and Metabolic Disorders Lab, Department of Food Science and Nutrition, College of Food and Agricultural Science, King Saud University, P.O. Box 2460, Riyadh 11451, Saudi Arabia.ORCID https://orcid.org/0000-0003-3973-1997
King Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The second most biggest cancer worldwide is breast cancer. There is an increasing need for safer, effective, and affordable drug candidates from natural sources to treat breast cancer. In the present investigation, the anticancer effect of

Indexed as

ApoptosisBreast NeoplasmsCaspasesCucurbitaDNA DamageFemaleFruitGene Expression Regulation, NeoplasticHumansMCF-7 CellsNeoplasm ProteinsPlant ExtractsRNA, MessengerStaining and LabelingTumor Suppressor Protein p53CaspasesNeoplasm ProteinsPlant ExtractsRNA, MessengerTumor Suppressor Protein p53

Identifiers

PMID32685475
PMCPMC7335397
OpenAlexW3037571867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.